1776 Wealth’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,825
Closed -$159K 249
2020
Q2
$159K Sell
1,825
-2,225
-55% -$192K 0.11% 114
2020
Q1
$357K Buy
4,050
+2,025
+100% +$181K 0.15% 102
2019
Q4
$191K Buy
+2,025
New +$182K 0.16% 102

Other funds holding NVS

1776 Wealth's NVS Position: Q3 2020 in Review

1776 Wealth sold out of Novartis (NVS) in Q3 2020, closing a stake of 1,825 shares — an estimated $159K sold.

1776 Wealth first reported a position in NVS in Q4 2019 and held it in 3 quarters. The position peaked at $357K in Q1 2020. 1,118 funds tracked by Wall St. Rank hold NVS as of Q3 2020.

  • 1776 Wealth reported no remaining Novartis position as of Q3 2020 after selling out during the quarter.
  • 1776 Wealth sold 1,825 Novartis shares in Q3 2020, an estimated $159K.
  • 1776 Wealth first reported a position in Novartis in Q4 2019 and held it in 3 quarters.
  • 1776 Wealth's Novartis position peaked at $357K in Q1 2020.
  • 1,118 funds tracked by Wall St. Rank held Novartis as of Q3 2020.

Based on 1776 Wealth's 13F filing for Q3 2020, filed 12 Nov 2020.